Founders, Collaborators, and Management Team
Sheila Mikhail, J.D., M.B.A., Founder / CEO. Ms. Mikhail is also a founder of Life Sciences Law, PLLC, Asklêpios BioPharmaceutical, Inc. and several university spin-outs. She has over 20 years experience in commercialization of technology, management consulting and corporate law.
Roger Hajjar, Ph.D., M.D., Scientific Founder /
Collaborator. Dr. Hajjar is the Director of Cardiovascular Research at
Evangelia Kranias, Ph.D., Scientific Founder /
Collaborator. Dr. Kranias is the Director of Cardiovascular Biology in
the Department of Pharmacology and Cell Biophysics at the
Jude Samulski, Ph.D., Scientific Founder / Collaborator.
Dr. Samulski is the Director of Gene Therapy at the
Gabor Rubanyi, M.D., Ph.D., Founder. Dr. Rubanyi was the Vice President and Head of the Gene Therapy Department at Berlex Biosciences where he led the preclinical and clinical development of the Ad5FGF-4 angiogenic gene therapy product through Phase III trials.
Clinical Advisory Board
William Abraham, M.D. Dr. Abraham is the director of the Division of Cardiovascular Medicine at The Ohio State University Medical Center and a professor of internal medicine.
Sir Magdi Yacoub, M.D. Sir Yacoub has performed more transplants than any other surgeon in the world. Sir Yacoub is currently the British Heart Foundation Professor of Cardiothoracic Surgery at Imperial College London (UK) and Founder and Director of Research at The Magdi Yacoub Institute, Heart Science Centre Harefield.